(prepared by applicant): The candidate, Beena Sood MD, is interested in pursuing an academic career in Neonatal-Perinatal medicine with the focus on patient oriented research. The areas of interest are the use of aerosolized medications I newborn, pulmonary biology, and pharmacologic manipulation of the pulmonary vasculature and ductus arteriosus. The candidate has been actively involved in research during her fellowship training. The institutional environment at the Wayne State University offers extensive resources available to the candidate The Division of Neonatal-Perinatal Medicine has a busy service both at Hutzel Hospital and Children's Hospital of Michigan. The career development plan includes formal mentorship, extensive coursework leading to a Master's of Science degree in Clinical Research Design and Statistical Analysis, conduct of clinical and complementary laboratory research related to the patient-oriented research. Dr. Sood's mentor, Seetha Shankaran, MD, is a renowned neonatologist with extensive experience in clinical research study design involved in several Multi center clinical trials through the NICHD Neonatal Research Network. She has established collaborative relationships with neonatologists throughout Michigan and the U.S. that will facilitate the studies proposed by Dr. Sood. JV Aranda MD, PhD and V Delaney-Black MD, MPH will be Consultants on the study. Dr Sood proposes a clinical trial for the use of aerosolized prostaglandin E1 (PGE1) as a selective pulmonary vasodilator in the treatment of persistent pulmonary hypertension (PPHN) in the newborn. T are two phases of the research plan. Initially, a phase I pilot study of aerosolized PGE1 in term and near- infants with PPHN will be conducted at the Children's Hospital of Michigan (already under way) in collaboration with other hospitals in the Detroit area to establish the appropriate dosing of PGEl. In the second phase, a randomized controlled study of the optimum dose of aerosolized Prostaglandin E1 (PGE1) in the units will be conducted to evaluate efficacy. If effective, a proposal for using aerosolized PGE1 in neonatal PPHN as a multicenter study will be submitted to the NICHD Neonatal Network.
| Sood, Beena G; Keszler, Martin; Garg, Meena et al. (2014) Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials. Trials 15:486 |
| Sood, Beena G; Latif, Zahid; Shen, Yimin et al. (2012) Aerosol delivery during high frequency jet ventilation: an MRI evaluation. Respir Care 57:1901-7 |
| SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Carlo, Waldemar A; Finer, Neil N et al. (2010) Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 362:1959-69 |
| Sood, Beena G; Madan, Ashima; Saha, Shampa et al. (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394-400 |
| Sood, Beena G; Chintala, Kavitha; Wykes, Susan et al. (2009) Effect of aerosolized PGE(1) on the ductus arteriosus of neonatal swine. Prostaglandins Other Lipid Mediat 90:49-54 |
| Sood, Beena G; Dawe, Elizabeth J; Maddipati, Krishna Rao et al. (2008) Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs. Pulm Pharmacol Ther 21:565-72 |
| Sood, Beena G; Shen, Yimin; Latif, Zahid et al. (2008) Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res 64:159-64 |
| Sood, Beena G; Peterson, Jennifer; Malian, Monica et al. (2007) Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res 56:531-41 |
| Sood, B G; Delaney-Black, V; Glibetic, M et al. (2007) PGE2/TXB2 imbalance in neonatal hypoxemic respiratory failure. Acta Paediatr 96:669-73 |
| Sood, Beena G; Glibetic, Maria; Aranda, Jacob V et al. (2006) Systemic levels following PGE1 inhalation in neonatal hypoxemic respiratory failure. Acta Paediatr 95:1093-8 |
Showing the most recent 10 out of 12 publications
